aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ATYR is expected to report earnings to fall 7.82% to -10 cents per share on November 05
Q3'26
Est.
$-0.10
Q1'26
Beat
by $0.03
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.09
Q2'25
Missed
by $0.04
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -13 cents. With 302.01K shares outstanding, the current market capitalization sits at 49.19M.